Stage IB Pancreatic Cancer Completed Phase 2 Trials for Nelfinavir (DB00220)

Indication	Status	Phase
DBCOND0034490 (Stage IB Pancreatic Cancer)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01959672	Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer	Treatment	Calcium (DB01373) Fluorouracil (DB00544) Gemcitabine (DB00441) Leucovorin (DB00650) Levoleucovorin (DB11596) Nelfinavir (DB00220) Oregovomab (DB04964)